-
Something wrong with this record ?
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
F. Soria, SF. Shariat, SP. Lerner, HM. Fritsche, M. Rink, W. Kassouf, PE. Spiess, Y. Lotan, D. Ye, MI. Fernández, E. Kikuchi, DC. Chade, M. Babjuk, AP. Grollman, GN. Thalmann,
Language English Country Germany
Document type Journal Article, Review
NLK
ProQuest Central
from 1997-02-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-02-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-02-01 to 1 year ago
- MeSH
- Colorectal Neoplasms, Hereditary Nonpolyposis epidemiology MeSH
- Carcinoma, Transitional Cell diagnostic imaging epidemiology pathology surgery MeSH
- Aristolochic Acids metabolism MeSH
- Kidney Pelvis diagnostic imaging pathology surgery MeSH
- Humans MeSH
- Lymph Node Excision MeSH
- Kidney Neoplasms diagnostic imaging epidemiology pathology surgery MeSH
- Urinary Bladder Neoplasms epidemiology MeSH
- Ureteral Neoplasms diagnostic imaging epidemiology pathology surgery MeSH
- Neoadjuvant Therapy MeSH
- Preoperative Care MeSH
- Prognosis MeSH
- Risk Factors MeSH
- Ureteroscopy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
PURPOSE: Upper-tract urothelial carcinoma (UTUC) is a relatively uncommon disease with limited available evidence on specific topics. The purpose of this article was to review the previous literature to summarize the current knowledge about UTUC epidemiology, diagnosis, preoperative evaluation and prognostic assessment. METHODS: Using MEDLINE, a non-systematic review was performed including articles between January 2000 and February 2016. English language original articles, reviews and editorials were selected based on their clinical relevance. RESULTS: UTUC accounts for 5-10 % of all urothelial cancers, with an increasing incidence. UTUC and bladder cancer share some common risk factors, even if they are two different entities regarding practical, biological and clinical characteristics. Aristolochic acid plays an important role in UTUC pathogenesis in certain regions. It is further estimated that approximately 10 % of UTUC are part of the hereditary non-polyposis colorectal cancer spectrum disease. UTUC diagnosis remains mainly based on imaging and endoscopy, but development of new technologies is rapidly changing the diagnosis algorithm. To help the decision-making process regarding surgical treatment, extent of lymphadenectomy and selection of neoadjuvant systemic therapies, predictive tools based on preoperative patient and tumor characteristics have been developed. CONCLUSIONS: Awareness regarding epidemiology, diagnosis, preoperative evaluation and prognostic assessment changes is essential to correctly diagnose and manage UTUC patients, thereby potentially improving their outcomes.
Department of Genitourinary Oncology Moffitt Cancer Center Tampa FL USA
Department of Surgery McGill University Montreal QC Canada
Department of Urology Bern University Hospital Bern Switzerland
Department of Urology Caritas St Josef Medical Centre University of Regensburg Regensburg Germany
Department of Urology Clinica Alemana Santiago Chile
Department of Urology Fudan University Shanghai Cancer Center Shanghai China
Department of Urology Keio University School of Medicine Tokyo Japan
Department of Urology University Medical Center Hamburg Eppendorf Hamburg Germany
Department of Urology University of Texas Southwestern Medical Center Dallas TX USA
Scott Department of Urology Baylor College of Medicine Houston TX USA
Urology Department University of Sao Paulo Medical School and Institute of Cancer São Paulo Brazil
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017059
- 003
- CZ-PrNML
- 005
- 20180516152531.0
- 007
- ta
- 008
- 180515s2017 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00345-016-1928-x $2 doi
- 035 __
- $a (PubMed)27604375
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Soria, Francesco $u Department of Urology, Medical University of Vienna, Vienna, Austria. Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.
- 245 10
- $a Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) / $c F. Soria, SF. Shariat, SP. Lerner, HM. Fritsche, M. Rink, W. Kassouf, PE. Spiess, Y. Lotan, D. Ye, MI. Fernández, E. Kikuchi, DC. Chade, M. Babjuk, AP. Grollman, GN. Thalmann,
- 520 9_
- $a PURPOSE: Upper-tract urothelial carcinoma (UTUC) is a relatively uncommon disease with limited available evidence on specific topics. The purpose of this article was to review the previous literature to summarize the current knowledge about UTUC epidemiology, diagnosis, preoperative evaluation and prognostic assessment. METHODS: Using MEDLINE, a non-systematic review was performed including articles between January 2000 and February 2016. English language original articles, reviews and editorials were selected based on their clinical relevance. RESULTS: UTUC accounts for 5-10 % of all urothelial cancers, with an increasing incidence. UTUC and bladder cancer share some common risk factors, even if they are two different entities regarding practical, biological and clinical characteristics. Aristolochic acid plays an important role in UTUC pathogenesis in certain regions. It is further estimated that approximately 10 % of UTUC are part of the hereditary non-polyposis colorectal cancer spectrum disease. UTUC diagnosis remains mainly based on imaging and endoscopy, but development of new technologies is rapidly changing the diagnosis algorithm. To help the decision-making process regarding surgical treatment, extent of lymphadenectomy and selection of neoadjuvant systemic therapies, predictive tools based on preoperative patient and tumor characteristics have been developed. CONCLUSIONS: Awareness regarding epidemiology, diagnosis, preoperative evaluation and prognostic assessment changes is essential to correctly diagnose and manage UTUC patients, thereby potentially improving their outcomes.
- 650 _2
- $a kyseliny aristolochové $x metabolismus $7 D034341
- 650 _2
- $a karcinom z přechodných buněk $x diagnostické zobrazování $x epidemiologie $x patologie $x chirurgie $7 D002295
- 650 _2
- $a dědičné nepolypózní kolorektální nádory $x epidemiologie $7 D003123
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory ledvin $x diagnostické zobrazování $x epidemiologie $x patologie $x chirurgie $7 D007680
- 650 _2
- $a ledvinná pánvička $x diagnostické zobrazování $x patologie $x chirurgie $7 D007682
- 650 _2
- $a lymfadenektomie $7 D008197
- 650 _2
- $a neoadjuvantní terapie $7 D020360
- 650 _2
- $a předoperační péče $7 D011300
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a nádory močovodu $x diagnostické zobrazování $x epidemiologie $x patologie $x chirurgie $7 D014516
- 650 _2
- $a ureteroskopie $7 D018666
- 650 _2
- $a nádory močového měchýře $x epidemiologie $7 D001749
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Shariat, Shahrokh F $u Department of Urology, Medical University of Vienna, Vienna, Austria. Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria. Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Department of Urology, Weill Cornell Medical College, New York, NY, USA.
- 700 1_
- $a Lerner, Seth P $u Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA.
- 700 1_
- $a Fritsche, Hans-Martin $u Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
- 700 1_
- $a Rink, Michael $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- 700 1_
- $a Kassouf, Wassim $u Department of Surgery (Urology), McGill University, Montreal, QC, Canada.
- 700 1_
- $a Spiess, Philippe E $u Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA.
- 700 1_
- $a Lotan, Yair $u Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- 700 1_
- $a Ye, Dingwei $u Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
- 700 1_
- $a Fernández, Mario I $u Department of Urology, Clinica Alemana, Santiago, Chile.
- 700 1_
- $a Kikuchi, Eiji $u Department of Urology, Keio University School of Medicine, Tokyo, Japan.
- 700 1_
- $a Chade, Daher C $u Urology Department, University of Sao Paulo Medical School and Institute of Cancer, São Paulo, Brazil.
- 700 1_
- $a Babjuk, Marko $u Department of Urology, Faculty Hospital Motol, Second Faculty of Medicine, Charles University in Praha, Prague, Czech Republic.
- 700 1_
- $a Grollman, Arthur P $u Department of Pharmacological Sciences and Department of Medicine, Stony Brook University, Stony Brook, NY, USA.
- 700 1_
- $a Thalmann, George N $u Department of Urology, Bern University Hospital, Bern, Switzerland. george.thalmann@insel.ch.
- 773 0_
- $w MED00004739 $t World journal of urology $x 1433-8726 $g Roč. 35, č. 3 (2017), s. 379-387
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27604375 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180516152706 $b ABA008
- 999 __
- $a ok $b bmc $g 1300683 $s 1013899
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 35 $c 3 $d 379-387 $e 20160907 $i 1433-8726 $m World journal of urology $n World J Urol $x MED00004739
- LZP __
- $a Pubmed-20180515
